Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02080845 · ClinicalTrials.gov registry record · NA
Effects of a Cocoa Shot on the Human Brain 2
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02080845: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT02080845 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02080845, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The Hershey Company is interested in investigating the effects of various chocolate beverages on brain physiology and cognitive function. The main substances in the drinks that are known to influence the brain are caffeine and related chemicals such as theobromine. Caffeine and chemicals related to caffeine are all naturally occurring and all potentially alter brain physiology. This study will evaluate changes in brain blood flow and cognition following the consumption of drinks with various combinations of the Primary Ingredients. The study proposed here will evaluate ingredients in a 4-arm cross-over double-blind design in an attempt to understand the differential effects of these compounds in chocolate drinks.
Primary Outcome
N-Back Task
Interventions
- DIETARY_SUPPLEMENT low theobromine
- DIETARY_SUPPLEMENT no caffeine
- DIETARY_SUPPLEMENT high caffeine
- DIETARY_SUPPLEMENT no theobromine
- DIETARY_SUPPLEMENT high theobromine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-03 |
| Phase | NA |
What the finished NCT02080845 record still lists
NCT02080845 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which low theobromine is the first listed.
NCT02080845 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02080845 about?
NCT02080845 is a clinical study titled "Effects of a Cocoa Shot on the Human Brain 2". The Hershey Company is interested in investigating the effects of various chocolate beverages on brain physiology and cognitive function. The main substances in the drinks that are known to influence the brain are caffeine and related chemicals such as theobromine. Caffeine and chemicals related to ...
What is the current status of trial NCT02080845?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2014-03. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02080845?
The interventions under investigation include: low theobromine (DIETARY_SUPPLEMENT), no caffeine (DIETARY_SUPPLEMENT), high caffeine (DIETARY_SUPPLEMENT), no theobromine (DIETARY_SUPPLEMENT), high theobromine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02080845?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02080845's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia